HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Reply to "Inferring clinical relevance of der p 23 from the restricted effect on treatment outcomes after tablet allergy immunotherapy".

AuthorsThomas Stranzl, Henrik Ipsen, Lars Harder Christensen, Thomas Eiwegger, Niels Johansen, Kaare Lund, Peter Sejr Andersen
JournalAllergy (Allergy) Vol. 76 Issue 4 Pg. 1300-1301 (04 2021) ISSN: 1398-9995 [Electronic] Denmark
PMID33840114 (Publication Type: Letter, Research Support, Non-U.S. Gov't, Comment)
Chemical References
  • Tablets
  • Immunoglobulin E
Topics
  • Humans
  • Hypersensitivity
  • Immunoglobulin E
  • Sublingual Immunotherapy
  • Tablets
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: